|
Phenotype
|
Conditions
|
Figures
|
|
female organism decreased fertility, abnormal
|
standard conditions
|
Fig. 3
from Yan et al., 2017
|
|
female organism brain hsd17b1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
female organism estradiol decreased amount, abnormal
|
standard conditions
|
Fig. 8
from Yan et al., 2017
|
|
female organism liver ins expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
female organism liver pparg expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
female organism liver vtg1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
female organism liver esr2a expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
female organism liver fabp4a expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
female organism liver insra expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
female organism liver esr1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
granulosa cell cyp19a1a expression absent, abnormal
|
standard conditions
|
Fig. 5 
from Yan et al., 2017
|
|
granulosa cell amh expression absent, abnormal
|
standard conditions
|
Fig. 5
from Yan et al., 2017
|
|
granulosa cell gata4 expression absent, abnormal
|
standard conditions
|
Fig. 5
from Yan et al., 2017
|
|
liver insrb expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
liver fabp10a expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
liver insb expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
liver lipid droplet increased amount, abnormal
|
standard conditions
|
Fig. 6
from Yan et al., 2017
|
|
male organism fertility, normal
|
standard conditions
|
Fig. 3
from Yan et al., 2017
|
|
male organism testis increased size, abnormal
|
standard conditions
|
Fig. 4
from Yan et al., 2017
|
|
muscle lipid droplet increased amount, abnormal
|
standard conditions
|
Fig. 6
from Yan et al., 2017
|
|
oocyte maturation disrupted, abnormal
|
standard conditions
|
Fig. 4
from Yan et al., 2017
|
|
oocyte stage I increased amount, abnormal
|
standard conditions
|
Fig. 3,
Fig. 4
from Yan et al., 2017
|
|
oocyte stage II increased amount, abnormal
|
standard conditions
|
Fig. 3,
Fig. 4
from Yan et al., 2017
|
|
oocyte stage III decreased amount, abnormal
|
standard conditions
|
Fig. 4
from Yan et al., 2017
|
|
oocyte stage IV absent, abnormal
|
standard conditions
|
Fig. 3,
Fig. 4
from Yan et al., 2017
|
|
ovary cyp17a1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary lhcgr expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary tp53 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary hsd17b3 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary casp3a expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary cyp11a1.1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary hsd17b1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary ctnnb1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary smad1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary gata4 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary amh expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary nr0b1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary fshr expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary hsd17b2 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary foxl2b expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary cyp19a1a expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
ovary cyp17a2 expression decreased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
Sertoli cell amh expression increased amount, abnormal
|
standard conditions
|
Fig. 5
from Yan et al., 2017
|
|
spermatid development process quality, normal
|
standard conditions
|
Fig. 4
from Yan et al., 2017
|
|
testis casp3a expression increased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
testis inhbb expression increased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
testis tp53 expression increased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
testis pcna expression increased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
testis ddx4 expression increased amount, abnormal
|
standard conditions
|
Fig. 5 ,
Fig. 7
from Yan et al., 2017
|
|
testis amh expression increased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
testis cyp11a1.1 expression increased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
testis fshr expression increased amount, abnormal
|
standard conditions
|
Fig. 7
from Yan et al., 2017
|
|
unfertilized egg decreased amount, abnormal
|
standard conditions
|
Fig. 3
from Yan et al., 2017
|
|
whole organism increased mass, abnormal
|
standard conditions
|
Fig. 6
from Yan et al., 2017
|
|
whole organism 11-oxotestosterone increased amount, abnormal
|
standard conditions
|
Fig. 8
from Yan et al., 2017
|
